Revance Therapeutics Inc (RVNC)
5.80
-0.10
(-1.69%)
USD |
NASDAQ |
Nov 01, 16:00
5.795
0.00 (0.00%)
After-Hours: 20:00
Revance Therapeutics Market Cap: 604.25M for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 604.25M |
| October 31, 2024 | 614.66M |
| October 30, 2024 | 616.75M |
| October 29, 2024 | 615.71M |
| October 28, 2024 | 614.66M |
| October 25, 2024 | 489.65M |
| October 24, 2024 | 552.16M |
| October 23, 2024 | 551.11M |
| October 22, 2024 | 551.11M |
| October 21, 2024 | 550.07M |
| October 18, 2024 | 551.11M |
| October 17, 2024 | 539.66M |
| October 16, 2024 | 550.07M |
| October 15, 2024 | 541.74M |
| October 14, 2024 | 535.49M |
| October 11, 2024 | 550.07M |
| October 10, 2024 | 547.99M |
| October 09, 2024 | 545.91M |
| October 08, 2024 | 543.82M |
| October 07, 2024 | 555.28M |
| October 04, 2024 | 543.82M |
| October 03, 2024 | 547.99M |
| October 02, 2024 | 540.70M |
| October 01, 2024 | 541.74M |
| September 30, 2024 | 540.70M |
| Date | Value |
|---|---|
| September 27, 2024 | 558.41M |
| September 26, 2024 | 561.53M |
| September 25, 2024 | 552.16M |
| September 24, 2024 | 572.47M |
| September 23, 2024 | 558.93M |
| September 20, 2024 | 605.29M |
| September 19, 2024 | 609.46M |
| September 18, 2024 | 624.04M |
| September 17, 2024 | 621.44M |
| September 16, 2024 | 621.96M |
| September 13, 2024 | 682.38M |
| September 12, 2024 | 683.42M |
| September 11, 2024 | 685.51M |
| September 10, 2024 | 684.47M |
| September 09, 2024 | 685.51M |
| September 06, 2024 | 685.51M |
| September 05, 2024 | 684.47M |
| September 04, 2024 | 685.51M |
| September 03, 2024 | 686.55M |
| August 30, 2024 | 684.47M |
| August 29, 2024 | 684.47M |
| August 28, 2024 | 685.51M |
| August 27, 2024 | 685.51M |
| August 26, 2024 | 685.51M |
| August 23, 2024 | 687.59M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
244.41M
Minimum
Jun 26 2024
3.161B
Maximum
May 09 2023
1.413B
Average
1.399B
Median
Market Cap Benchmarks
| Recursion Pharmaceuticals Inc | 1.806B |
| Moderna Inc | 21.00B |
| Pacira BioSciences Inc | 764.32M |
| PetIQ Inc | -- |
| Anebulo Pharmaceuticals Inc | 47.72M |
Market Cap Related Metrics
| PS Ratio | 2.196 |
| Price | 5.80 |
| Earnings Yield | -55.17% |